As an injectable therapy or oral pills, Semaglutide plays a crucial role in obesity management by improving insulin sensitivity , reducing appetite, and helping individuals create a caloric deficit to manage their weight effectively
To learn more about Semaglutide, weight loss strategies, and other resources tailored to women's health, visit Fem Excel
Unlike earlier compounds that targeted only the GLP-1 receptor, tirzepatide was engineered to engage the GIP receptor with higher affinity while also showing a distinct signaling pattern at the GLP-1 receptor, a property scientists describe as biased agonism. From a basic science perspective, tirzepatide serves as a valuable reference tool for exploring incretin receptor biology, pancreatic beta-cell signaling, and the intersection of metabolic and appetite regulation pathways
As body fat decreases, mechanical load drops and inflammatory cytokine production falls
In a world that chronically underinvests in womens health, could we leverage the GLP-1 wins to put effort into minimizing the devastating consequences of obesitys metabolic cousin, anorexia, that ironically has been exacerbated by the use and abuse of GLP-1 agonists